No Detail Found!

Screening the Biomarkers and Related Medicines for Gastric Adenocarcinoma

Author(s)
Juanjuan Lin Department of Scientific Research Section, Shenzhen Longhua District Central Hospital,Shenzhen,China
Ning Xu Department of Radiology, Shenzhen Longhua District Central Hospital,Shenzhen,China
Weifang An Department of Pathology, Shenzhen Longhua District Central Hospital,Shenzhen,China
Abstract
Objective: To search for potential biomarkers and available medicines for gastric adenocarcinoma. Study Design: Experimental study. Place and Duration of the Study: Scienti c Research Section, Shenzhen Longhua District Central Hospital, Shenzhen, China,from January to April 2023. Methodology: Datasets were retrieved from the Gene Expression Omnibus (GEO). Di erential gene expression analysis between gastric adenocarcinoma and normal samples was conducted using GEO2R. Subsequent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed via the Enrichr website. Protein-protein interaction (PPI) networks were established using the STRING website. The central hub genes were identi ed using the cytoHubba plugin integrated within Cytoscape. Finally, the GEPIA2 and QuartataWeb websites were employed to validate the expression levels of the hub genes and to identify potential medicines for gastric adenocarcinoma. Results: In total, 133 DEGs were identi ed. GO analysis revealed that these DEGs predominantly participate in processes such as cell adhesion, positive regulation of cell proliferation, and extracellular matrix organisation. In the KEGG pathways, DEGs were signi cantly enriched in gastric acid secretion, protein digestion and absorption, and ECM-receptor interaction. Following the construction of the PPI network, 10 central hub genes were identi ed and validated using GEPIA2. Notably, among these hub genesS,ERPINE1 demonstrated a signi cant association with the prognosis of gastric adenocarcinoma, and potential therapeutic agents were subsequently predicted. Conclusion: SERPINE1 and potential therapeutic agents hold promise to enhance personalised diagnosis and treatment for gastric adenocarcinoma patients in the future.
Publication Details
Page(s) 290-295
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 3, Year: 2024

Request the full text from PASTIC

Keywords
Bioinformatics, Gastric adenocarcinoma, Biomarkers, Di erentially Expressed Genes (DEGs)
0

Citations

0

Downloads

55

Views